DexCom (NASDAQ:DXCM) reported second-quarter 2026 revenue growth of 13% from a year earlier, supported by continued demand ...

Shares of medical device company DexCom (NASDAQ:DXCM) jumped 10.9% in the morning session after the company reported strong ...

Selected devices will be exempt from certain premarket requirements while manufacturers collect real-world data through ...

Dexcom G7 15 Day is the longest‑lasting and most accurate 1-4 CGM system authorized by Health Canada, providing real-time glucose readings for an industry-leading 15.5 days 5. BURNABY, British ...

DexCom (DXCM) has been back on radar after its recent share price move, with the stock closing at $74.85. Investors are ...

Ladies and gentlemen, welcome to the Dexcom Second Quarter 2026 Earnings Release Conference Call. My name is Abby, and I will be your operator for today's call. [Operator Instructions] As a reminder, ...

The device demonstrates a MARD of 8% and includes a 12-hour grace period and mobile app compatibility.

Adults in the US who want to measure their blood glucose levels using a wearable sensor will soon be able to buy one over-the-counter (OTC) for the first time. The FDA has cleared Dexcom’s Stelo as ...

Wall Street ended higher on Friday, lifted by Amazon as the tech heavyweight's strong quarterly report bolstered investor confidence in AI-related stocks, while Apple dropped after its results ...

Under the TEMPO pilot program, Dexcom can receive Medicare reimbursement when seniors receive care from their software.